The cost-effectiveness of long-term antiviral therapy in the management of HBeAg-positive and HBeAg-negative chronic hepatitis B in Singapore

The purpose of this study was the economic evaluation of short-duration treatments of chronic hepatitis B (CHB) and longer duration antiviral treatment for up to 5 years. Two 10-health state Markov models were developed for hepatitis B e antigen (HBeAg)-positive and HBeAg-negative CHB patients respe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lacey, L F, Gane, E
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2007
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2156151/
https://www.ncbi.nlm.nih.gov/pubmed/17927611
http://dx.doi.org/10.1111/j.1365-2893.2007.00865.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2156151/
https://www.ncbi.nlm.nih.gov/pubmed/17927611
http://dx.doi.org/10.1111/j.1365-2893.2007.00865.x

Ejemplares similares